Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
A pragmatic monitoring framework might include: Baseline blood pressure measurement (ideally on two separate occasions) before initiating treatment Repeat measurements at each dose-escalation visit , typically every four weeks during titration Ongoing monitoring every three to six months once a stable maintenance dose is achieved Home blood pressure monitoring encouraged for patients with known hypertension or those on antihypertensive therapy
Kristensen SL, Lindhardsen J, Ahlehoff O, Erichsen R, Lamberts M, Khalid U, et al
Please Note: You are also required to complete a form at checkout
In Studies 2 (NCT#03548935), 3 (NCT#03552757), and 4 (NCT#03611582), WEGOVY or matching placebo was escalated to 2.4 mg subcutaneous injection weekly during a 16-week period followed by 52 weeks on maintenance dose
Pricing: $199/month for compounded injectable or sublingual semaglutide, $249/month for semaglutide tablets, $299/month for tirzepatide (injectable or tablet)
On average, patients should anticipate taking these medications for at least 12 months
US$ 26.46
US$ 20.11
US$ 26.91
US$ 21.16
US$ 26.06
US$ 27.34
US$ 26.06
